• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

亨廷顿舞蹈病运动迟缓的客观评估:临床关联及两年随访

Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up.

作者信息

van Vugt Jeroen P P, Piet Karlijne K E, Vink Liesbeth J, Siesling Sabine, Zwinderman Aeilko H, Middelkoop Huub A M, Roos Raymund A C

机构信息

Department of Neurology, Leiden University Medical Centre, Leiden, The Netherlands.

出版信息

Mov Disord. 2004 Mar;19(3):285-97. doi: 10.1002/mds.10718.

DOI:10.1002/mds.10718
PMID:15022182
Abstract

Functional disability of patients with Huntington's disease (HD) is determined by impairment of voluntary motor function rather than the presence of chorea. However, only few attempts have been made to quantify this motor impairment. By using a simple reaction time paradigm, we measured the time needed for movement initiation (akinesia) and execution (bradykinesia) in 76 HD patients and 127 controls. Akinesia and bradykinesia were already evident in early stages and increased linearly with increasing disease stage. Quantified motor slowness correlated with clinical impairment of voluntary movements but also with cognitive impairment and medication use. In patients without severe cognitive impairment, quantified motor slowness reflected clinical motor impairment more purely. During 1.9 years follow-up (range, 0.8-3.8 years), quantified akinesia and bradykinesia progressed concomitantly with progression of clinical impairment of voluntary movements, cognition, and functional capacity. However, rate of change in motor slowness did not discriminate between patients whose disease stage remained stable and those whose disease stage progressed. We conclude that the reaction time paradigm may be used to quantify akinesia and bradykinesia in HD, at least in patients without severe cognitive impairment. Although reaction and movement times increased in time, these measures failed to detect functionally important changes during our follow-up period.

摘要

亨廷顿舞蹈症(HD)患者的功能残疾是由自主运动功能受损决定的,而非舞蹈症的存在。然而,仅有少数研究尝试对这种运动障碍进行量化。通过使用简单反应时范式,我们测量了76例HD患者和127例对照者开始运动(运动不能)和执行运动(运动迟缓)所需的时间。运动不能和运动迟缓在疾病早期就已明显,并随疾病阶段的增加呈线性增加。量化的运动迟缓与自主运动的临床损伤相关,但也与认知损伤和药物使用有关。在没有严重认知损伤的患者中,量化的运动迟缓更纯粹地反映了临床运动损伤。在1.9年的随访期间(范围为0.8 - 3.8年),量化后的运动不能和运动迟缓与自主运动、认知和功能能力的临床损伤进展同步。然而,运动迟缓的变化率并不能区分疾病阶段保持稳定的患者和疾病阶段进展的患者。我们得出结论,反应时范式可用于量化HD患者的运动不能和运动迟缓,至少对于没有严重认知损伤的患者是如此。尽管反应时间和运动时间随时间增加,但在我们的随访期间,这些测量未能检测到功能上的重要变化。

相似文献

1
Objective assessment of motor slowness in Huntington's disease: clinical correlates and 2-year follow-up.亨廷顿舞蹈病运动迟缓的客观评估:临床关联及两年随访
Mov Disord. 2004 Mar;19(3):285-97. doi: 10.1002/mds.10718.
2
Complex movement behaviour and progression of Huntington's disease.亨廷顿舞蹈症的复杂运动行为与病情进展
Neurosci Lett. 2007 Apr 18;416(3):272-4. doi: 10.1016/j.neulet.2007.02.027. Epub 2007 Feb 11.
3
Alterations in voluntary movement execution in Huntington's disease are related to the dominant motor system: evidence from event-related potentials.亨廷顿舞蹈症患者自主运动执行的改变与主导运动系统有关:来自事件相关电位的证据。
Exp Neurol. 2009 Mar;216(1):148-57. doi: 10.1016/j.expneurol.2008.11.018. Epub 2008 Dec 10.
4
[Huntington chorea. Clinical correlations and preliminary neuropsychological data].[亨廷顿舞蹈病。临床关联及初步神经心理学数据]
Acta Neurol (Napoli). 1992 Aug-Dec;14(4-6):530-6.
5
Bradykinesia in Huntington's disease. A prospective, follow-up study.亨廷顿舞蹈症中的运动迟缓。一项前瞻性随访研究。
J Neurol. 2002 Apr;249(4):437-40. doi: 10.1007/s004150200035.
6
Correlates of early disability in Huntington's disease.亨廷顿舞蹈病早期残疾的相关因素
Ann Neurol. 1986 Dec;20(6):727-31. doi: 10.1002/ana.410200613.
7
Effects of rivastigmine on motor and cognitive impairment in Huntington's disease.卡巴拉汀对亨廷顿舞蹈病运动和认知障碍的影响。
Mov Disord. 2004 Dec;19(12):1516-8. doi: 10.1002/mds.20235.
8
[Evolution of locomotion disorders in Huntington's disease].[亨廷顿舞蹈症中运动障碍的演变]
Neurophysiol Clin. 2008 Apr;38(2):117-25. doi: 10.1016/j.neucli.2008.01.003. Epub 2008 Feb 21.
9
Two years' follow-up of rivastigmine treatment in Huntington disease.卡巴拉汀治疗亨廷顿病的两年随访
Clin Neuropharmacol. 2007 Jan-Feb;30(1):43-6. doi: 10.1097/01.wnf.0000240945.44370.f0.
10
Clinical relevance of electrophysiological tests in the assessment of patients with Huntington's disease.电生理检查在亨廷顿病患者评估中的临床相关性
Mov Disord. 2002 Nov;17(6):1294-301. doi: 10.1002/mds.10273.

引用本文的文献

1
Action impulsivity and attention deficits in patients at an early stage of Huntington disease.亨廷顿病早期患者的行动冲动性与注意力缺陷
J Neural Transm (Vienna). 2025 May;132(5):645-654. doi: 10.1007/s00702-025-02888-1. Epub 2025 Mar 3.
2
Impact of Upper Limb Function on Activities of Daily Living and Quality of Life in Huntington's Disease.上肢功能对亨廷顿舞蹈病患者日常生活活动及生活质量的影响
J Clin Med. 2024 Dec 31;14(1):168. doi: 10.3390/jcm14010168.
3
Validation Study of a German Cognitive Battery for Huntington's Disease: Relationship Between Cognitive Performance, Functional Decline, and Disease Burden.
一项用于亨廷顿病的德国认知电池的验证研究:认知表现、功能下降和疾病负担之间的关系。
Arch Clin Neuropsychol. 2021 Jan 15;36(1):74-86. doi: 10.1093/arclin/acaa038.
4
Perceptions of the impact of chorea on health-related quality of life in Huntington disease (HD): A qualitative analysis of individuals across the HD spectrum, family members, and clinicians.亨廷顿病(HD)舞蹈病对健康相关生活质量影响的认知:对 HD 谱系个体、家庭成员和临床医生的定性分析。
Neuropsychol Rehabil. 2020 Jul;30(6):1150-1168. doi: 10.1080/09602011.2018.1564675. Epub 2019 Mar 8.
5
Walking-Related Dual-Task Interference in Early-to-Middle-Stage Huntington's Disease: An Auditory Event Related Potential Study.早中期亨廷顿舞蹈症患者步行相关的双任务干扰:一项听觉事件相关电位研究
Front Psychol. 2017 Jul 31;8:1292. doi: 10.3389/fpsyg.2017.01292. eCollection 2017.
6
Characterising Upper Limb Movements in Huntington's Disease and the Impact of Restricted Visual Cues.亨廷顿舞蹈症上肢运动特征及视觉线索受限的影响
PLoS One. 2015 Aug 6;10(8):e0133709. doi: 10.1371/journal.pone.0133709. eCollection 2015.
7
Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohort.抗精神病药和相关药物在亨廷顿氏症法语人群队列中的疗效。
PLoS One. 2014 Jan 15;9(1):e85430. doi: 10.1371/journal.pone.0085430. eCollection 2014.
8
Organoselenium bis selenide attenuates 3-nitropropionic acid-induced neurotoxicity in rats.有机硒化双硒化物可减轻大鼠 3-硝基丙酸诱导的神经毒性。
Neurotox Res. 2013 Apr;23(3):214-24. doi: 10.1007/s12640-012-9336-5. Epub 2012 Jun 28.
9
Changes in the relationship between movement velocity and movement distance in primary focal hand dystonia.原发性局灶性手部肌张力障碍中运动速度与运动距离关系的变化。
J Mot Behav. 2008 Jul;40(4):301-13. doi: 10.3200/JMBR.40.4.301-314.
10
Hand tapping: a simple, reproducible, objective marker of motor dysfunction in Huntington's disease.手部轻敲:亨廷顿舞蹈病中运动功能障碍的一种简单、可重复的客观标志物。
J Neurol. 2008 Aug;255(8):1145-52. doi: 10.1007/s00415-008-0859-x. Epub 2008 May 13.